Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.
Kenji KanenawaKyohei YamajiTakeshi MorimotoKo YamamotoTakenori DomeiMakoto HyodoHiroki ShiomiYutaka FurukawaYoshihisa NakagawaKazushige KadotaHirotoshi WatanabeYusuke YoshikawaTomohisa TadaJunichi TazakiNatsuhiko EharaRyoji TaniguchiToshihiro TamuraAtsushi IwakuraTakeshi TadaSatoru SuwaMamoru ToyofukuTsukasa InadaKazuhisa KanedaTatsuya OgawaTeruki TakedaHiroshi SakaiTakashi YamamotoKeiichi TambaraJiro EsakiHiroshi EizawaMiho YamadaEiji ShinodaJunichiro NishizawaHiroshi MabuchiNobushige TamuraManabu ShirotaniShogo NakayamaTakashi UegaitoMitsuo MatsudaMamoru TakahashiMoriaki InokoNaoki KanemitsuTakashi TamuraKatsuhisa IshiiRyuzo NawadaTomoya OnoderaNobuhisa OhnoTadaaki KoyamaHiroshi TsuneyoshiHiroki SakamotoTakeshi AoyamaShinji MikiMasaru TanakaYukihito SatoFumio YamazakiMichiya HanyuYoshiharu SogaTatsuhiko KomiyaKenji MinatoyaKenji AndoTakeshi KimuraPublished in: Journal of cardiology (2024)
Lower baseline LDL-C levels were associated with more comorbidities and a significantly higher risk of death, regardless of cardiovascular or non-cardiovascular causes, in patients who underwent coronary revascularization.